What is ICD-10 code F13.182?

F13.182 is the ICD-10-CM diagnosis code for Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder. Misuse of sedatives, sleeping pills, or anti-anxiety medications that causes sleep disturbances such as insomnia or abnormal sleep patterns. F13.182 is a billable code, meaning it can be reported on a claim as a primary or secondary diagnosis when supported by documentation. F13.182 is part of the FY2026 ICD-10-CM code set published by the CMS National Center for Health Statistics and used on Medicare, Medicaid, and commercial claims in the United States.

Yes. F13.182 is a billable ICD-10-CM code that can be reported on professional and institutional claims as a primary or secondary diagnosis when the provider documentation supports the specific condition described. Billable codes in ICD-10-CM are coded to the highest level of specificity available for the documented diagnosis. F13.182 is current for fiscal year 2026 and remains in the active CMS ICD-10-CM code set published by the National Center for Health Statistics.

Which HCC does F13.182 map to under V28?

F13.182 maps to CMS-HCC V28 HCC 137 (Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications). The category numbers, labels, and conditions come from the CMS-HCC V28 model file for payment year 2026.

2026 ICD-10-CM F13.182: Sedative, hypnotic

F13.182 maps to CMS-HCC V28 137. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · free HCC coding tools

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

Code lookupF13.182

Effective periodFY2026 Apr Update (Apr 1-Sep 30)

FY 2026 Apr update / Mental, Behavioral and Neurodevelopmental disorders (F01-F99) / Mental and behavioral disorders due to psychoactive substance use (F10-F19)

F13.182

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder

Misuse of sedatives, sleeping pills, or anti-anxiety medications that causes sleep disturbances such as insomnia or abnormal sleep patterns.

Buddy Insight

Sleep disorder induced by sedatives represents a paradoxical clinical scenario where medications designed to promote sleep actually cause sleep disturbances.

Overview Risk Models Code Book Documentation Audit Notes Edition comparison

CMS-HCC V28

Mapped

HCC 137

Drug Use Disorder, Moderate/S...

Code-level coefficient reference

CMS-HCC V24

Historical

Not used for standard CY2026 Medicare Advantage payment. Select a historical period to review V24.

Not used for CY2026 payment

ACA/HHS

Mapped

HCC 082

HHS-HCC 082 adult, RAF varies...

Code-level coefficient reference

ESRD/PACE

Mapped

HCC 55

Substance Use Disorder/Modera...

Code-level coefficient reference

RXHCC

N/A

—

Not risk-adjusted for this model/period.

Not mapped

Code Book Path

Official

F13.1Sedative, hypnotic or anxiolytic-related abuse F13.18Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorders F13.182Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder

Inclusion Terms

Official

No inclusion terms are included in this display for F13.182. Check the code and parent instructions in the Code Book.

Excludes 2

Official

symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)Inherited from F01-F99

Related Codes

Official

F13.180Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced anxiety disorder F13.181Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sexual dysfunction F13.188Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder

Includes

Official

disorders of psychological developmentInherited from F01-F99

Excludes 1

Official

sedative, hypnotic or anxiolytic-related dependence (F13.2-)Inherited from F13.1
sedative, hypnotic, or anxiolytic use, unspecified (F13.9-)Inherited from F13.1

Code First

Official

No Code First sequencing instructions are included in this display for F13.182. Check the code and parent instructions in the Code Book.

Use Additional

Official

No Use Additional Code instructions are included in this display for F13.182. Check the code and parent instructions in the Code Book.

Code Also

Official

No Code Also instructions are included in this display for F13.182. Check the code and parent instructions in the Code Book.

Buddy Documentation Tip

HCC Buddy guidance

Specific sedative, hypnotic, or anxiolytic substance identified

Type of sleep disturbance documented (insomnia, hypersomnia, parasomnia, circadian rhythm disruption)

Provider attribution of sleep disorder to the substance use

Substance use pattern meeting abuse criteria

MEAT Support

HCC Buddy guidance

Specific sedative, hypnotic, or anxiolytic substance identified

Type of sleep disturbance documented (insomnia, hypersomnia, parasomnia, circadian rhythm disruption)

Provider attribution of sleep disorder to the substance use

Substance use pattern meeting abuse criteria

Audit Caution

HCC Buddy guidance

Coding a primary sleep disorder instead of the substance-induced combination code

Confusing rebound insomnia from withdrawal with a substance-induced sleep disorder during active use

Missing the paradoxical nature of hypnotic-induced sleep problems and not querying the provider

Defaulting to uncomplicated abuse when documentation supports an induced sleep disorder

Common Mistakes

HCC Buddy guidance

F13.282 — Sedative DEPENDENCE with induced sleep disorder; requires documented dependence

F13.982 — Unspecified sedative use with induced sleep disorder; use when abuse vs dependence is unclear

G47.00 — Insomnia, unspecified; does not capture substance-induced etiology

F13.10 — Uncomplicated sedative abuse; misses the sleep disorder complication

Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →

Is F13.182 an HCC code?

Yes. F13.182 (Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder) maps to HCC 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 0.424. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.

Coder answer: F13.182 is billable and maps to V28 HCC 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.

Code: F13.182
Description: Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder
HCC (V28): HCC 137 — Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications
RAF reference coefficient: 0.424
Billable: Yes
Payment year: 2026

HCC Category Mapping

V28HCC 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications

0.424

ESRDHCC 55, Substance Use Disorder/Moderate/Severe/Substance Use with Complications

Not separately weighted

These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.

Work F13.182 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →

MEAT review for F13.182

For F13.182, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.

MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
EEvaluate: test results, medication response, or physical findings reviewed by the provider
AAssess: explicit mention in the assessment or plan with acknowledgment of status
TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Coder workflow notes

Get the V28 mapping + MEAT cheat sheet

One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.

Free PDF. No card. Unsubscribe anytime.

What This Code Means

F13.182 is the ICD-10-CM diagnosis code for sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced sleep disorder. Misuse of sedatives, sleeping pills, or anti-anxiety medications that causes sleep disturbances such as insomnia or abnormal sleep patterns. F13.182 sits in the ICD-10-CM chapter for mental, behavioral and neurodevelopmental disorders (f01-f99), within the section covering mental and behavioral disorders due to psychoactive substance use (f10-f19).

Under the CMS-HCC V28 risk adjustment model, F13.182 maps to Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications (HCC 137) with a source-labeled community, non-dual, aged reference coefficient of 0.424. No V24 mapping is shown for F13.182; use the applicable model and payment year when reviewing the V28 mapping. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.

Document the specific sleep problem (insomnia, hypersomnia, parasomnia) when possible. For F13.182, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for F13.182 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

•Document the specific sleep problem (insomnia, hypersomnia, parasomnia) when possible
•This paradoxically reflects sleep disorders caused by substances meant to improve sleep

Clinical Significance

Sleep disorder induced by sedatives represents a paradoxical clinical scenario where medications designed to promote sleep actually cause sleep disturbances. This is commonly seen with chronic benzodiazepine use and indicates a clinically significant complication of substance abuse. The presence of an induced disorder reflects greater disease burden than uncomplicated abuse and carries implications for both treatment planning and risk adjustment.

Documentation Requirements

✓Specific sedative, hypnotic, or anxiolytic substance identified
✓Type of sleep disturbance documented (insomnia, hypersomnia, parasomnia, circadian rhythm disruption)
✓Provider attribution of sleep disorder to the substance use
✓Substance use pattern meeting abuse criteria
✓Differentiation from rebound insomnia during withdrawal versus ongoing sleep disorder during active use
✓Sleep assessment findings or sleep study results if available

Commonly Confused Codes

•F13.282: Sedative DEPENDENCE with induced sleep disorder; requires documented dependence
•F13.982: Unspecified sedative use with induced sleep disorder; use when abuse vs dependence is unclear
•G47.00: Insomnia, unspecified; does not capture substance-induced etiology
•F13.10: Uncomplicated sedative abuse; misses the sleep disorder complication
•F13.230: Sedative dependence with withdrawal uncomplicated; withdrawal-related sleep issues differ from induced sleep disorder